Short stature in children with sickle cell anemia correlates with alterations in the IGF-I axis

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 2, 2007, Pages 211-218

  Collett Solberg, Paulo F ^a   Fleenor, Don ^b   Schultz, William H ^c   Ware, Russell E ^c  

^a Duke University Medical Center ^*  (Brazil)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Growth hormone deficiency; IGF I; IGFBP 3; Proteases; Short stature; Sickle cell anemia

Indexed keywords

DODECYL SULFATE SODIUM; PROTEINASE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; GROWTH HORMONE; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 3 PROTEASE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 PROTEASE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BODY HEIGHT; BONE AGE; CHILD GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVITY; FEMALE; GROWTH RATE; HUMAN; MALE; PATHOGENESIS; PROTEIN DEGRADATION; RADIOIMMUNOASSAY; SCHOOL CHILD; SHORT STATURE; SICKLE CELL ANEMIA; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; AGING; BLOOD; CHILD; GROWTH; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADOLESCENT; AGING; ANEMIA, SICKLE CELL; BODY HEIGHT; CHILD; ENDOPEPTIDASES; FEMALE; GROWTH; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE;

EID: 34247107156     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2007.20.2.211     Document Type: Article

References (21)

1. Steinberg MH. Management of sickle cell disease. N Engl J Med 1999; 340: 1021-1030.
2. Platt OS, Rosenstock W, Espeland M.A. Influence of sickle hemoglobinopathies on growth and development. N Engl J Med 1984; 311: 7-12.
3. Phebus CK, Gloninger MF, Maciak BJ. Growth patterns by age and sex in children with sickle cell disease. J Pediatr 1984; 105: 28-33.
4. Stevens MCG, Maude GH, Cupidore L, Jackson H, Hayes RJ, Serjeant GR. Prepubertal growth and skeletal maturation in children with sickle cell disease. Pediatrics 1986; 78: 124-132.
5. Brinker MR, Thomas KA, Meyers SJ, Texada T, Humbert JR, Cook SD, Gitter R. Bone mineral density of the lumbar spine and proximal femur is decreased in children with sickle cell anemia. Am J Orthop 1998; 27: 43-39.
6. Soliman AT, Bererhi H, Darwish A, Alzalabani MM, Wali Y, Ansari B. Decreased bone mineral density in prepubertal children with sickle cell disease: correlation with growth parameters, degree of siderosis and secretion of growth factors. J Trop Pediatr 1998; 44: 194-198.
7. Hazmi MAF, Bahakim HM, Al-Fawaz I. Endocrine functions in sickle cell anaemia patients. J Trop Pediatr 1992; 38: 307-313.
8. Evliyaoglu N, Kilinc Y, Sargin O. Thyroid functions in mild and severe forms of sickle cell anemia. Acta Paediatr Jpn 1996; 38: 460-463.
9. Collett-Solberg P, Cohen P. Role of insulin-like growth factor (IGF) binding proteins and proteases in modulating IGF action. Endocrin Metabol Clin N Am 1996; 25: 591-614.
10. Canale VC, Steinherz, New M, Erlandson M. Endocrine function in thalassemia major. Ann NY Acad Sci 1974; 232: 333-345.
11. Oberfield SE, Wethers DL, Kirkland JL, Levine LS. Growth hormone response to growth hormone releasing factor in sickle cell disease. Am J Pediatr Hematol Oncol 1987; 9: 331-334.
12. Rosenfeld RG. Disorders of growth hormone and insulin-like growth factor secretion and action. In: Sperling MA, ed. Pediatric Endocrinology. Philadelphia, PA: W.B. Saunders Co., 1996; 117-170.
13. Heyman MB Vichinsky E, Katz R, Gaffield B, Hurst D, Castillo R, Chiu D, Kleman K, Ammann AJ, Thaler MM, Lubin B. Growth retardation in sickle-cell disease treated by nutritional support. Lancet 1985; i: 903-906.
14. Gray NT, Brtlett JM, Kolasa KM, Marcuard SP, Holbrook CT, Horner RD. Nutritional status and dietary intake of children with sickle cell anemia. Am J Pediatr Hematol Oncol 1992; 14: 57-61.
15. Finan AC, Elmer MA, Sasanow SR, McKinney S, Russell MO, Gill FM. Nutritional factors and growth in children with sickle cell disease. Am J Dis Child 1988; 142: 237-240.
16. Barden EM, Zemel BS, Kawchak DA, Goran MI, Ohene-Frempong K, Stallings VA. Total and resting energy expenditure in children with sickle cell disease. J Pediatr 2000; 136: 73-79.
17. Barden EM, Kawchak DA, Ohene-Frempong K, Stallings VA, Zemel BA. Body composition in children with sickle cell disease. Am J Clin Nutr 2002; 76: 218-225.
18. Collett-Solberg PF, Cohen P. Genetics, chemistry, and function of the IGF/IGFBP system. Endocrine 2000; 12: 121-136.
19. Luporini SM, Bendit I, Manhani R, Bracco OL, Manzella L, Giannella-Neto D. Growth hormone and insulin-like growth factor 1 axis and growth of children with different sickle cell anemia haplotypes. J Pediatr Hematol Oncol 2001; 23: 357-363.
20. Weinzimer SA, Gibson TB, Collett-Solberg PF, Khare A, Liu B, Cohen P. Transferrin is an insulin-like growth factor-binding protein-3 binding protein. J Clin Endocrinol Metab 2001; 86: 1806-1813.
21. Soliman AT, Elzalabany M, Amer M, Ansari BM. Growth and pubertal development in transfusion dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study. J Trop Pediatr 1999; 45: 23-30.